Under construction – not a live service

Skip to content

Frontlight Research

Trial site

DermResearch, Inc. (Site 0056)

Austin, Texas, United StatesNot linked to an institution yet

0running trials
1closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

No running trial is registered here.

Researchers

No researcher is linked here yet.

Closed trials

Completed
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
NCT05119855· Phase 3· Source

Site data: ClinicalTrials.govUpdated 3 Nov 2026

Report an error

Under construction, not live – DermResearch, Inc. (Site 0056): trial site – Frontlight Research